Relumins Advanced Glutathione — Class II drug recall D-1319-2014
Completed recall by Flawless Beauty LLC, reported 2014-05-21, distributed nationwide. Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be u
| Recall number | D-1319-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Flawless Beauty LLC, Asbury Park, NJ, United States |
| Recall initiated | 2014-04-29 |
| Classified | 2014-05-13 |
| Reported by FDA | 2014-05-21 |
| Distributed | Nationwide (US) |
| Reason classes | labeling, unapproved product |
| UPC / GTIN / UDI-DI | 00700175760302 |
| Lot numbers | 06/16, 130616 |
Product
Relumins Advanced Glutathione (lyophilized glutathione/vitamin C) injectable solution, 1500 mg/500 mg, packaged in 8-count vials, 8-count 5 mL vitamin C (ascorbic acid) solution diluent ampoules, and 30-count Advanced Glutathione Boosters capsules per box, Relumins Labs, 183 Locust Avenue, West Long Branch, NJ 07764, UPC 700175760302
Reason for recall
Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used parenterally for drug claims.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1319-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.